Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 24 June 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Hazardous drinking remains underdiagnosed and undermanaged

Hazardous drinking remains underdiagnosed and undermanaged, the BSG conference has been told.

News image

fiogf49gjkf04

Researchers from the Liver Unit at the Sheffield Teaching Hospitals in Sheffield, England, established the prevalence and detection rate of hazardous drinking in unselected hospital patients.

They then attempted to ascertain whether, in patients who presented with a first episode of decompensated alcoholic liver disease (ALD), opportunities to manage excessive drinking during previous admissions had been exploited.

On specific weekdays over a 9-month period, all patients aged 30-60 years, admitted to the admissions unit under the care of a general physician or surgeon, were considered for screening using the Alcohol Use Disorders Identification Test (AUDIT) questionnaire.

A total of 281 patients answered the questionnaire and 46 patients (16%) had an AUDIT score greater than 9.

BSG delegates were told that, within this group of 46 subjects, 40 had an alcohol history taken on admission, with excessive drinking being reported by 27.

Excessive drinking was classified as drinking more than 21 units of alcohol per week in the case of men, and more than 14 units of alcohol per week in women.

The research team found that, despite this level of excessive drinking, in only 15 of the 46 patients (33%), was it possible to reveal an awareness of hazardous drinking upon subsequent review of the continuity notes relating to the admission.

Furthermore, in only 12 of the 46 (26%), had action been taken about the drinking problem.

The researchers found that laboratory evidence of alcohol excess (raised MCV, gamma-GT or AST/ALT ratio, reduced platelets) was present in 30 of the 46 patients with an AUDIT score greater than 9.

In only 26% of hazardous drinkers had action been taken about the problem.
BSG
However, in only 15 of the 30 had these markers been identified during admission of the patients, and in only 12 (40%) had action been taken as a result of these findings.

The researchers also reviewed the notes of 68 of 71 patients with first presentation of decompensated ALD, who had previously been admitted to local hospitals (237 episodes).

In 156 such admission episodes (60%), laboratory data or patient symptoms suggested excessive drinking.

Admission alcohol history had been recorded more than once in 63 patients (93%), but this only equated to 68% of previous admissions.

A total of 41 of these 63 patients reported drinking greater than 60 units of alcohol per week (men) or more than 40 units of alcohol per week (women).

Of these, awareness of excessive drinking was evident from the continuity notes of nearly 90% of subjects, yet action had only been taken in just over 63% of cases.

Researcher E. J. Williams said the group's findings showed that, "Hazardous drinking remains common, underdiagnosed, and undermanaged in hospital inpatients.

"Brief counseling for hazardous drinkers can lead to reduced alcohol consumption, hence detection is important."

BSG
20 March 2002

Go to top of page Email this page Email this page to a colleague

 31 May 2018 
Diagnostic for NAFLD  
 31 May 2018 
Bile acids and the risks for hepatotoxicity
 31 May 2018 
Rectal cancer female sexuality score
 30 May 2018 
Fungal dysbiosis in cirrhosis
 30 May 2018 
Placebo rates in ulcerative colitis trials
 30 May 2018 
Follow-up testing and colorectal cancer mortality
 29 May 2018 
Organ transplantation donors
 29 May 2018 
Novel therapies for IBD
 29 May 2018 
Helicobacter pylori infection to stomach cancer
 28 May 2018 
Mesalazine in ulcerative colitis
 28 May 2018 
Technology and management of digestive diseases
 28 May 2018 
Therapeutic strategies for HCV
 25 May 2018 
Post‐operative complications in elderly IBD
 25 May 2018 
Technology to increase colorectal cancer screening
 25 May 2018 
Colorectal cancer–specific mortality
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Precision medicine for tumors
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
New therapies for CDI
 15 May 2018 
Hep B in the Grey Zone
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Chronic Hep B
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Symptom assessment in cirrhotic ascites
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
European guidelines on pancreatic cystic neoplasms

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us